PN

Priyanka Nitin Raut

Director Director DIN 10366951
DIN 10366951 First appointment Oct 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2023
Shareholding value •••• Premium profile

About Priyanka Nitin Raut

Data last updated:

Priyanka Nitin Raut was a Director at Xleap Care Private Limited (2023–2024) and Director at Soprah Marketing Private Limited (2023–2024). The companies operate in Pharma.

DIN 10366951
Primary Designation Director
Industry Pharma
First Appointment 23 Oct 2023

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xleap Care Private Limited U20237DL2023PTC422382
Director07 Nov 20232023Active
Soprah Marketing Private Limited U47912DL2023PTC421767
Director23 Oct 20232023₹1.15 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Xleap Care Private Limited
Soprah Marketing Private Limited
Premium access

Shareholding and investment profile for Priyanka Nitin Raut

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka Nitin Raut

Priyanka Nitin Raut was first appointed on 23 Oct 2023 as Director at Soprah Marketing Private Limited.

Priyanka Nitin Raut held 2 earlier board appointments: Xleap Care Private Limited (Director, 07 Nov 2023 to 15 Oct 2024); Soprah Marketing Private Limited (Director, 23 Oct 2023 to 03 Sep 2024).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available